Investigating anticarcinogenic compounds as an alternative to chemo

Comment: PD-1 targeting MK-3475 gives long-term responses in melanoma

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (against)

Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients

WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies

The use of imaging in treatment strategies

Breast cancer screening in the UK: does it work?

Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy

Mobile health solutions for breast cancer management in rural areas

Engineering of polymeric nanoparticles for medical applications

Combined use of PET and MRI imaging

Chemosaturation therapy for cancers in the liver